221 related articles for article (PubMed ID: 33621242)
1. Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers.
Head SA; Hernandez-Alias X; Yang JS; Ciampi L; Beltran-Sastre V; Torres-Méndez A; Irimia M; Schaefer MH; Serrano L
PLoS Biol; 2021 Feb; 19(2):e3001138. PubMed ID: 33621242
[TBL] [Abstract][Full Text] [Related]
2. SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion.
Conn VM; Gabryelska M; Marri S; Stringer BW; Ormsby RJ; Penn T; Poonnoose S; Kichenadasse G; Conn SJ
Cells; 2020 Nov; 9(11):. PubMed ID: 33207694
[TBL] [Abstract][Full Text] [Related]
3. Neuronal-specific microexon splicing of
Capponi S; Stöffler N; Irimia M; Van Schaik FMA; Ondik MM; Biniossek ML; Lehmann L; Mitschke J; Vermunt MW; Creyghton MP; Graybiel AM; Reinheckel T; Schilling O; Blencowe BJ; Crittenden JR; Timmers HTM
RNA Biol; 2020 Jan; 17(1):62-74. PubMed ID: 31559909
[TBL] [Abstract][Full Text] [Related]
4. SRRM4-dependent neuron-specific alternative splicing of protrudin transcripts regulates neurite outgrowth.
Ohnishi T; Shirane M; Nakayama KI
Sci Rep; 2017 Jan; 7():41130. PubMed ID: 28106138
[TBL] [Abstract][Full Text] [Related]
5. Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development.
Quesnel-Vallières M; Irimia M; Cordes SP; Blencowe BJ
Genes Dev; 2015 Apr; 29(7):746-59. PubMed ID: 25838543
[TBL] [Abstract][Full Text] [Related]
6. A mutation in the Srrm4 gene causes alternative splicing defects and deafness in the Bronx waltzer mouse.
Nakano Y; Jahan I; Bonde G; Sun X; Hildebrand MS; Engelhardt JF; Smith RJ; Cornell RA; Fritzsch B; Bánfi B
PLoS Genet; 2012; 8(10):e1002966. PubMed ID: 23055939
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
Coleman DJ; Sampson DA; Sehrawat A; Kumaraswamy A; Sun D; Wang Y; Schwartzman J; Urrutia J; Lee AR; Coleman IM; Nelson PS; Dong X; Morrissey C; Corey E; Xia Z; Yates JA; Alumkal JJ
Neoplasia; 2020 Jun; 22(6):253-262. PubMed ID: 32403054
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of a transcriptional repressor rescues hearing in a splicing factor-deficient mouse.
Nakano Y; Wiechert S; Fritzsch B; Bánfi B
Life Sci Alliance; 2020 Dec; 3(12):. PubMed ID: 33087486
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR-Cas9 Interrogation of Splicing Networks Reveals a Mechanism for Recognition of Autism-Misregulated Neuronal Microexons.
Gonatopoulos-Pournatzis T; Wu M; Braunschweig U; Roth J; Han H; Best AJ; Raj B; Aregger M; O'Hanlon D; Ellis JD; Calarco JA; Moffat J; Gingras AC; Blencowe BJ
Mol Cell; 2018 Nov; 72(3):510-524.e12. PubMed ID: 30388412
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network.
Lee AR; Gan Y; Tang Y; Dong X
EBioMedicine; 2018 Sep; 35():167-177. PubMed ID: 30100395
[TBL] [Abstract][Full Text] [Related]
11. RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
Labrecque MP; Brown LG; Coleman IM; Lakely B; Brady NJ; Lee JK; Nguyen HM; Li D; Hanratty B; Haffner MC; Rickman DS; True LD; Lin DW; Lam HM; Alumkal JJ; Corey E; Nelson PS; Morrissey C
Cancer Res; 2021 Sep; 81(18):4736-4750. PubMed ID: 34312180
[TBL] [Abstract][Full Text] [Related]
12. SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis.
Deshpande K; Martirosian V; Nakamura BN; Das D; Iyer M; Reed M; Shao L; Bamshad D; Buckley NJ; Neman J
Neuro Oncol; 2024 Feb; 26(2):309-322. PubMed ID: 37716001
[TBL] [Abstract][Full Text] [Related]
13. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
[TBL] [Abstract][Full Text] [Related]
14. Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
Gan Y; Li Y; Long Z; Lee AR; Xie N; Lovnicki JM; Tang Y; Chen X; Huang J; Dong X
EBioMedicine; 2018 May; 31():267-275. PubMed ID: 29759485
[TBL] [Abstract][Full Text] [Related]
15. A novel protein domain in an ancestral splicing factor drove the evolution of neural microexons.
Torres-Méndez A; Bonnal S; Marquez Y; Roth J; Iglesias M; Permanyer J; Almudí I; O'Hanlon D; Guitart T; Soller M; Gingras AC; Gebauer F; Rentzsch F; Blencowe BJ; Valcárcel J; Irimia M
Nat Ecol Evol; 2019 Apr; 3(4):691-701. PubMed ID: 30833759
[TBL] [Abstract][Full Text] [Related]
16. A highly conserved program of neuronal microexons is misregulated in autistic brains.
Irimia M; Weatheritt RJ; Ellis JD; Parikshak NN; Gonatopoulos-Pournatzis T; Babor M; Quesnel-Vallières M; Tapial J; Raj B; O'Hanlon D; Barrios-Rodiles M; Sternberg MJ; Cordes SP; Roth FP; Wrana JL; Geschwind DH; Blencowe BJ
Cell; 2014 Dec; 159(7):1511-23. PubMed ID: 25525873
[TBL] [Abstract][Full Text] [Related]
17. Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.
Quesnel-Vallières M; Dargaei Z; Irimia M; Gonatopoulos-Pournatzis T; Ip JY; Wu M; Sterne-Weiler T; Nakagawa S; Woodin MA; Blencowe BJ; Cordes SP
Mol Cell; 2016 Dec; 64(6):1023-1034. PubMed ID: 27984743
[TBL] [Abstract][Full Text] [Related]
18. Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.
Nakano Y; Wiechert S; Bánfi B
Cell Rep; 2019 Apr; 27(3):860-871.e8. PubMed ID: 30995482
[TBL] [Abstract][Full Text] [Related]
19. SRRM4 gene expression correlates with neuroendocrine prostate cancer.
Li Y; Zhang Q; Lovnicki J; Chen R; Fazli L; Wang Y; Gleave M; Huang J; Dong X
Prostate; 2019 Jan; 79(1):96-104. PubMed ID: 30155992
[TBL] [Abstract][Full Text] [Related]
20. Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions.
Gonatopoulos-Pournatzis T; Niibori R; Salter EW; Weatheritt RJ; Tsang B; Farhangmehr S; Liang X; Braunschweig U; Roth J; Zhang S; Henderson T; Sharma E; Quesnel-Vallières M; Permanyer J; Maier S; Georgiou J; Irimia M; Sonenberg N; Forman-Kay JD; Gingras AC; Collingridge GL; Woodin MA; Cordes SP; Blencowe BJ
Mol Cell; 2020 Mar; 77(6):1176-1192.e16. PubMed ID: 31999954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
